DK112793A - Fremgangsmåde til fremstilling af krystallinsk type A botulinium toxin som et terapeutisk medikament - Google Patents

Fremgangsmåde til fremstilling af krystallinsk type A botulinium toxin som et terapeutisk medikament

Info

Publication number
DK112793A
DK112793A DK112793A DK112793A DK112793A DK 112793 A DK112793 A DK 112793A DK 112793 A DK112793 A DK 112793A DK 112793 A DK112793 A DK 112793A DK 112793 A DK112793 A DK 112793A
Authority
DK
Denmark
Prior art keywords
preparation
botulinum toxin
therapeutic drug
crystalline type
crystalline
Prior art date
Application number
DK112793A
Other languages
English (en)
Other versions
DK112793D0 (da
Inventor
Genji Sakaguchi
Tomoko Shimizu
Original Assignee
Chiba Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba Prefecture filed Critical Chiba Prefecture
Publication of DK112793D0 publication Critical patent/DK112793D0/da
Publication of DK112793A publication Critical patent/DK112793A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK112793A 1992-10-28 1993-10-08 Fremgangsmåde til fremstilling af krystallinsk type A botulinium toxin som et terapeutisk medikament DK112793A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4311158A JPH06192296A (ja) 1992-10-28 1992-10-28 治療用医薬品としての結晶a型ボツリヌス毒素の製造法。

Publications (2)

Publication Number Publication Date
DK112793D0 DK112793D0 (da) 1993-10-08
DK112793A true DK112793A (da) 1994-04-29

Family

ID=18013801

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112793A DK112793A (da) 1992-10-28 1993-10-08 Fremgangsmåde til fremstilling af krystallinsk type A botulinium toxin som et terapeutisk medikament

Country Status (6)

Country Link
JP (1) JPH06192296A (da)
DE (1) DE4335366A1 (da)
DK (1) DK112793A (da)
FR (1) FR2697163B1 (da)
GB (1) GB2272697A (da)
SE (1) SE9303323L (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919665A (en) 1989-10-31 1999-07-06 Ophidian Pharmaceuticals, Inc. Vaccine for clostridium botulinum neurotoxin
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
US8187612B2 (en) 1993-12-28 2012-05-29 Allergan, Inc. Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US8557256B2 (en) 1993-12-28 2013-10-15 Allergan, Inc. Treatment for cervical dystonia with the neurotoxic component of a botulinum toxin
AU709586B2 (en) * 1994-10-24 1999-09-02 Ophidian Pharmaceuticals, Inc. Vaccine and antitoxin for treatment and prevention of C. difficile disease
JP2003009897A (ja) 2001-07-03 2003-01-14 Keiji Oguma ボツリヌス毒素の分離・精製法
RU2257914C1 (ru) * 2004-03-31 2005-08-10 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства Здравоохранения Российской Федерации Способ лечения паралитического косоглазия
CN102614264A (zh) * 2012-05-02 2012-08-01 马守云 一种治疗眼脸痉挛的药物
RU2535115C1 (ru) * 2013-05-15 2014-12-10 Бости Трейдинг Лтд Фармацевтический состав, содержащий нейротоксин ботулина
KR101775682B1 (ko) 2015-11-30 2017-09-06 주식회사 대웅 보툴리눔 독소의 제조방법
WO2024191217A1 (ko) 2023-03-16 2024-09-19 주식회사 대웅 다중모드 크로마토그래피를 이용한 개선된 보툴리눔 독소의 정제방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940005589B1 (ko) * 1986-04-02 1994-06-21 다이닛뽄세이야꾸 가부시끼가이샤 핵산 또는 엔도톡신의 제거제 및 제거방법
US5053005A (en) * 1989-04-21 1991-10-01 Gary E. Borodic Chemomodulation of curvature of the juvenile spine

Also Published As

Publication number Publication date
JPH06192296A (ja) 1994-07-12
GB2272697A (en) 1994-05-25
GB9321794D0 (en) 1993-12-15
SE9303323L (sv) 1994-04-29
DE4335366A1 (de) 1994-05-05
DK112793D0 (da) 1993-10-08
FR2697163B1 (fr) 1995-06-23
SE9303323D0 (sv) 1993-10-11
FR2697163A1 (fr) 1994-04-29

Similar Documents

Publication Publication Date Title
FI910389L (fi) Foerfarande foer framstaellning av ett transdermalt terapeutiskt system med tulobuterol som aktivt aemne.
IS2537B (is) Lyfjablanda til inngjafar um húð
DK323889D0 (da) Fremgangsmaade til fremstilling af et fritstroemmende, granulaert vaskemiddel
DK0537971T3 (da) Fremgangsmåde til administration af algoritme-uafhængige kryptografinøgler
FI914603A7 (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen pyridiinijohdannaisen valmistamiseksi
DK0812195T3 (da) Farmaceutisk sammensætning til piperidinoalkanolforbindelser
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
FI925633A0 (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
PH25389A (en) Novel thiazole derivatives active on the cholinergic system, process for obtention, pharmaceutical compositions
DK112793A (da) Fremgangsmåde til fremstilling af krystallinsk type A botulinium toxin som et terapeutisk medikament
NO175714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere
FI913775A7 (fi) 17-asemassa substituoidut kortikoidi-17-alkyyliakrbonaatit, menetelmä niiden valmistamiseksi ja niitä sisältävät lääkeaineet
IS3814A (is) Aðferð til framleiðslu á lyfjablöndum
NO174766C (no) Fremgangsmåte til fremstilling av en doseringsenhet for kontrollert administrering av diltiazem
DK645788D0 (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO173239C (no) Analogifremgangsmaate til fremstilling av et terapeutisk aktivt etopodofyllotoksinglukosidacylderivat
DK0648738T3 (da) Fremgangsmåde til fremstilling af acetoacetarylamider
DK0648748T3 (da) Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2
DK0458855T3 (da) Farmaceutisk præparat til behandling af tonsillitis
FI101600B1 (fi) Menetelmä farmaseuttisen formulaation valmistamiseksi
FI932209L (fi) Foerfarande foer framstaellning av magnesiumkloridpartiklar med maongplanig struktur, magnesiumkloridpartiklar med maongplanig struktur, katalytkomponent buren av dessa partiklar och polyolefiner som erhaolls ur denna katalytkomponent
DK153592A (da) Fremgangsmåde til fremstilling af 2,3,5,6-tetrachlorpyridin
DK196591D0 (da) Anvendelse af en kendt kemisk forbindelse til fremstilling af et farmaceutisk paraeparat til topisk applikation
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment